Archived – Updated Safety Information Addressing the Risk of Malignancies Associated with REMICADE (Infliximab) – Schering Canada Inc.
Critical priority
The issue
Product safety
Where it was sold
ON, QCReported in the official notice — confirm there.
Issued by
Health Canada — Marketed health products
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.